The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis

In this retrospective study using the National Cancer DataBase, the unfavorable median overall survival in patients diagnosed with renal cell carcinoma with sarcomatoid differentiation was found to be caused by the high number of cases diagnosed with late-stage disease. Additionally, surgical therapy was associated with favorable overall survival across all stages. Background: Sarcomatoid differentiation in patients diagnosed with renal cell carcinoma (sRCC) imply aggressive behavior and often metastatic disease at the time of diagnosis. We aim to examine the overall survival (OS) in patients with sRCC using the National Cancer Database (NCDB). Materials and Methods: We identified patients diagnosed with sRCC between 2010-2015. We employed Kaplan-Meier curves and multivariable Cox proportional hazards regression models to examine the impact of several potential risk factors on OS in patients diagnosed with sRCC. Results: In total, 8582 patients with renal cancer were found to have sarcomatoid differentiation, with 4105 patients (47.8%) being diagnosed with AJCC stage IV disease. The median OS was 17.2 months (IQR 5.4, 68.7 months). Compared to patients who did not undergo surgery, OS was significantly longer in patients undergoing partial or total nephrectomy across all stages. This result remained consistent on multivariable Cox proportional hazards regression adjusting for patient and tumor characteristics (Surgery: Hazard ratio 0.54, 95%Confidence interval 0.43 - 0.68, P < .001). Conclusion: In our cohort sRCC was found to have an unfavorable median OS, which was mainly caused by the high number of cases diagnosed with late-stage disease. Additionally, surgery was associated with favorable OS across all stages. This study supports the notion that surgical therapy, even in the setting of cytoreductive surgery, provides a survival benefit in patients with sRCC.

Automated summary

This retrospective study using the National Cancer DataBase found that the unfavorable median overall survival in patients diagnosed with renal cell carcinoma with sarcomatoid differentiation was mainly caused by a high number of cases diagnosed with late-stage disease. Additionally, surgical therapy was associated with favorable overall survival across all stages. This study supports the notion that surgical therapy provides a survival benefit in patients with sRCC.